Patent · US Expired

7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof

US6534651B2 · kind B2 · utility

18Cited by
9References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 19, 2001
Grant dateMar 18, 2003
Priority date
Expiry dateJan 19, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H19/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides a novel class of substituted isoindolinone derivatives, useful for the treatment of inflammation and reperfusion injuries. Pharmaceutical compositions, and methods of making and using the compounds, or pharmaceutically acceptable salts, hydrates, stereoisomers or mixtures thereof are also described. The novel isoindolinone derivatives have the formula: or a pharmaceutically acceptable base or acid addition salt, hydrate, stereoisomer, or mixtures thereof, wherein R14 is described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.